Sahlgrenska Center for Cardiovascular and Metabolic Research, Department of Molecular and Clinical Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Obesity (Silver Spring). 2011 Nov;19(11):2280-2. doi: 10.1038/oby.2011.251. Epub 2011 Aug 18.
Increased visceral fat, as opposed to subcutaneous/gluteal, most strongly relates to key metabolic dysfunctions including insulin resistance, hepatic steatosis, and inflammation. Mesenteric fat hypertrophy in patients with Crohn's disease and in experimental rodent models of gut inflammation suggest that impaired gut barrier function with increased leakage of gut-derived antigens may drive visceral lipid deposition. The aim of this study was to determine whether increased intestinal permeability is associated with visceral adiposity in healthy humans. Normal to overweight female subjects were recruited from a population-based cohort. Intestinal permeability was assessed using the ratio of urinary excretion of orally ingested sucralose to mannitol (S/M). In study 1 (n = 67), we found a positive correlation between waist circumference and S/M excretion within a time frame of urine collection consistent with permeability of the lower gastrointestinal tract (6-9 hours post-ingestion; P = 0.022). These results were followed up in study 2 (n = 55) in which we used computed tomography and dual energy X-ray absorptiometry to measure visceral and subcutaneous fat areas of the abdomen, liver fat content, and total body fat of the same women. The S/M ratio from the 6-12 h urine sample correlated with visceral fat area (P = 0.0003) and liver fat content (P = 0.004), but not with subcutaneous or total body fat. This novel finding of an association between intestinal permeability and visceral adiposity and liver fat content in healthy humans suggests that impaired gut barrier function should be further explored as a possible mediator of excess visceral fat accumulation and metabolic dysfunction.
内脏脂肪的增加,与皮下/臀肌脂肪的增加相反,与包括胰岛素抵抗、肝脂肪变性和炎症在内的关键代谢功能障碍关系最密切。克罗恩病患者和肠道炎症实验啮齿动物模型中的肠系膜脂肪肥大表明,肠道屏障功能受损,肠道来源的抗原漏出增加,可能导致内脏脂肪沉积。本研究旨在确定在健康人群中,肠道通透性的增加是否与内脏肥胖有关。从基于人群的队列中招募了正常至超重的女性受试者。使用口服摄入的蔗糖素与甘露醇(S/M)的尿液排泄比值来评估肠道通透性。在研究 1(n = 67)中,我们发现,在与下消化道通透性一致的尿液收集时间段内(摄入后 6-9 小时;P = 0.022),腰围与 S/M 排泄呈正相关。在研究 2(n = 55)中,我们对相同的女性进行了腹部计算机断层扫描和双能 X 射线吸收法测量,以测量腹部内脏和皮下脂肪面积、肝脏脂肪含量和全身脂肪。6-12 小时尿液样本的 S/M 比值与内脏脂肪面积(P = 0.0003)和肝脏脂肪含量(P = 0.004)相关,但与皮下脂肪或全身脂肪无关。这一在健康人群中发现的肠道通透性与内脏肥胖和肝脏脂肪含量之间的关联表明,肠道屏障功能受损应进一步作为内脏脂肪过度积累和代谢功能障碍的可能介导因素进行探索。